Vici, Patrizia <br/><br/>
Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Mar 2011 
 - 687-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-010-1369-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anthracyclines--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>BRCA1 Protein--genetics<br/>Breast Neoplasms--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Paclitaxel--administration & dosage<br/>Ribonucleoside Diphosphate Reductase<br/>Survival<br/>Time Factors<br/>Treatment Outcome<br/>Tumor Suppressor Proteins--genetics<br/>Young Adult<br/>Gemcitabine